{"id":"https://openalex.org/W2062926560","doi":"https://doi.org/10.1517/14728222.2012.660307","title":"Hitting a complex target: an update on interleukin-6 trans-signalling","display_name":"Hitting a complex target: an update on interleukin-6 trans-signalling","alternate_titles":[],"publication_year":2012,"publication_date":"2012-02-01","ids":{"openalex":"https://openalex.org/W2062926560","doi":"https://doi.org/10.1517/14728222.2012.660307","mag":"2062926560","pmid":"https://pubmed.ncbi.nlm.nih.gov/22324903"},"language":"en","primary_location":{"id":"doi:10.1517/14728222.2012.660307","doi":"https://doi.org/10.1517/14728222.2012.660307","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728222.2012.660307","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2062926560"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013428965","display_name":"Georg H. Waetzig","orcid":"https://orcid.org/0000-0001-8289-2097","observed_orcids":["https://orcid.org/0000-0001-8289-2097"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]},{"id":"https://openalex.org/I4210105421","display_name":"Conaris","ror":"https://ror.org/01j9kqj67","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210105421"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georg H Waetzig","raw_affiliation_strings":["Christian-Albrechts-University Kiel, Institute of Biochemistry, Kiel, Germany","CONARIS Research Institute AG,\nSchauenburgerstrasse 116, D-24118 Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christian-Albrechts-University Kiel, Institute of Biochemistry, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]},{"raw_affiliation_string":"CONARIS Research Institute AG,\nSchauenburgerstrasse 116, D-24118 Kiel, Germany","institution_ids":["https://openalex.org/I4210105421"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089057275","display_name":"Stefan Rose\u2010John","orcid":"https://orcid.org/0000-0002-7519-3279","observed_orcids":["https://orcid.org/0000-0002-7519-3279"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefan Rose-John","raw_affiliation_strings":["Christian-Albrechts-University Kiel, Institute of Biochemistry, Olshausenstrasse 40, D-24098 Kiel, Germany +49 431 880 3336; +49 431 880 5007; rosejohn@biochem.uni-kiel.de","Christian-Albrechts-University Kiel, Institute of Biochemistry,\nOlshausenstrasse 40, D-24098 Kiel, Germany +49 431 880 3336"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christian-Albrechts-University Kiel, Institute of Biochemistry, Olshausenstrasse 40, D-24098 Kiel, Germany +49 431 880 3336; +49 431 880 5007; rosejohn@biochem.uni-kiel.de","institution_ids":["https://openalex.org/I32021983"]},{"raw_affiliation_string":"Christian-Albrechts-University Kiel, Institute of Biochemistry,\nOlshausenstrasse 40, D-24098 Kiel, Germany +49 431 880 3336","institution_ids":["https://openalex.org/I32021983"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.306,"has_fulltext":false,"cited_by_count":95,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80887728,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"16","issue":"2","first_page":"225","last_page":"236"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9879999756813049},{"id":"https://openalex.org/keywords/il-6-trans-signalling","display_name":"IL-6 trans-signalling","score":0.9570000171661377},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/soluble-gp130","display_name":"soluble gp130","score":0.722000002861023},{"id":"https://openalex.org/keywords/sgp130fc","display_name":"sgp130Fc","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9520000219345093},{"id":"https://openalex.org/keywords/il-6-receptor","display_name":"IL-6 receptor","score":0.6430000066757202},{"id":"https://openalex.org/keywords/il-6-inhibitors","display_name":"IL-6 inhibitors","score":0.6790000200271606},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C39743133","wikidata":"https://www.wikidata.org/wiki/Q3262595","display_name":"Signalling","level":2,"score":0.7634699940681458},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.5581468343734741},{"id":"https://openalex.org/C3018449070","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signalling pathways","level":3,"score":0.5295599102973938},{"id":"https://openalex.org/C88498014","wikidata":"https://www.wikidata.org/wiki/Q14859918","display_name":"Hedgehog signaling pathway","level":3,"score":0.5046414136886597},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4754723608493805},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4664095640182495},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3778197467327118},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.36476147174835205},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3637923300266266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36200857162475586},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33147597312927246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30406874418258667},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2822980284690857},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.262988418340683},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1378641426563263},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0820501446723938}],"mesh":[{"descriptor_ui":"D000093242","descriptor_name":"Interleukin-6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14728222.2012.660307","doi":"https://doi.org/10.1517/14728222.2012.660307","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728222.2012.660307","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},{"id":"pmid:22324903","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22324903","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W1496369310","https://openalex.org/W1510936315","https://openalex.org/W1523903893","https://openalex.org/W1597588755","https://openalex.org/W1849537180","https://openalex.org/W1902385211","https://openalex.org/W1904767156","https://openalex.org/W1904816508","https://openalex.org/W1967723169","https://openalex.org/W1968558772","https://openalex.org/W1969421278","https://openalex.org/W1971308765","https://openalex.org/W1979540550","https://openalex.org/W1982322400","https://openalex.org/W1985236996","https://openalex.org/W1989542542","https://openalex.org/W1994607862","https://openalex.org/W1995485558","https://openalex.org/W1996650419","https://openalex.org/W2007606465","https://openalex.org/W2009535353","https://openalex.org/W2012967865","https://openalex.org/W2018239666","https://openalex.org/W2018261512","https://openalex.org/W2018498519","https://openalex.org/W2021865808","https://openalex.org/W2029527585","https://openalex.org/W2032658955","https://openalex.org/W2034607409","https://openalex.org/W2036988498","https://openalex.org/W2037324712","https://openalex.org/W2040901874","https://openalex.org/W2053806896","https://openalex.org/W2055560719","https://openalex.org/W2057671535","https://openalex.org/W2067761476","https://openalex.org/W2074299086","https://openalex.org/W2077231697","https://openalex.org/W2082626794","https://openalex.org/W2089567564","https://openalex.org/W2097615936","https://openalex.org/W2105269215","https://openalex.org/W2107682360","https://openalex.org/W2110317317","https://openalex.org/W2110463517","https://openalex.org/W2111091679","https://openalex.org/W2114853101","https://openalex.org/W2116004164","https://openalex.org/W2116569673","https://openalex.org/W2117521006","https://openalex.org/W2122402883","https://openalex.org/W2127786010","https://openalex.org/W2131930163","https://openalex.org/W2134285290","https://openalex.org/W2142585662","https://openalex.org/W2148793188","https://openalex.org/W2150333647","https://openalex.org/W2152181022","https://openalex.org/W2157233685","https://openalex.org/W2161757643","https://openalex.org/W2162146381","https://openalex.org/W2165797008","https://openalex.org/W2171799063","https://openalex.org/W2319958192"],"related_works":["https://openalex.org/W4366085911","https://openalex.org/W2731047190","https://openalex.org/W3198352553","https://openalex.org/W7214102134","https://openalex.org/W1989542542","https://openalex.org/W2024171722","https://openalex.org/W1773554359","https://openalex.org/W4381851507","https://openalex.org/W2522977978","https://openalex.org/W2040736784"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Interleukin-6":[1],"(IL-6)":[2],"is":[3,67,184],"a":[4,26,139,194],"key":[5],"target":[6,97],"in":[7,94,135,161,177,198],"inflammation":[8],"and":[9,84,150,152,190],"cancer.":[10],"Selective":[11],"inhibition":[12],"of":[13,79,86,126,163],"IL-6":[14,33,38,44,50,98,104,166,175,202],"trans-signalling":[15,60,89,115,151,181],"could":[16],"provide":[17],"the":[18,42,48,59,63,77,80,108,118,123,136,145,164,172,178,188],"same":[19],"or":[20,71,99],"even":[21],"higher":[22],"therapeutic":[23,154,174],"efficacy":[24],"with":[25,37,138,200],"better":[27],"side":[28],"effect":[29],"profile":[30,197],"than":[31],"complete":[32,201],"inhibition.":[34],"Animal":[35],"studies":[36,143],"inhibitors":[39],"show":[40],"that":[41],"classic":[43,149],"signalling":[45],"pathway":[46,61],"via":[47,62],"membrane-bound":[49],"receptor":[51,121],"(IL-6R)":[52],"has":[53],"important":[54],"physiological":[55],"functions,":[56],"whereas":[57],"blocking":[58],"soluble":[64,119],"IL-6R":[65,100],"(sIL-6R)":[66],"sufficient":[68],"to":[69,76,170,186],"prevent":[70],"treat":[72],"IL-6-driven":[73],"diseases.":[74],"Due":[75],"success":[78],"anti-IL-6R":[81],"antibody":[82],"tocilizumab":[83],"difficulties":[85],"constructing":[87],"selective":[88],"inhibitors,":[90],"most":[91],"drug":[92],"candidates":[93],"clinical":[95],"development":[96],"and,":[101],"thus,":[102],"both":[103],"pathways.":[105],"By":[106],"contrast,":[107],"fusion":[109],"protein":[110],"sgp130Fc":[111,183],"selectively":[112],"targets":[113],"IL-6/sIL-6R":[114],"by":[116],"utilising":[117],"gp130":[120],"as":[122],"natural":[124],"inhibitor":[125,176,182],"trans-signalling.":[127],"AREAS":[128],"COVERED:":[129],"The":[130,180],"authors":[131],"summarise":[132],"recent":[133],"developments":[134],"field":[137],"focus":[140],"on":[141],"animal":[142],"highlighting":[144],"mechanistic":[146],"differences":[147],"between":[148],"their":[153],"implications.":[155],"EXPERT":[156],"OPINION:":[157],"Characterising":[158],"disease":[159],"mechanisms":[160],"terms":[162],"employed":[165],"pathways":[167],"will":[168],"help":[169],"select":[171],"right":[173],"future.":[179],"about":[185],"enter":[187],"clinic":[189],"holds":[191],"promise":[192],"for":[193],"clinically":[195],"different":[196],"comparison":[199],"inhibitors.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2062926560","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
